Kardigan, Inc.

KARD chart

Kardigan, Inc. news

• UBS Maintains Kardigan(KARD.US) With Buy Rating, Maintains Target Price $25

  Moomoo · Nov 10, 10:01 AM EST

• Kardigan: Granted Underwriters 30-Day Option to Purchase Up to an Additional 3,750,000 Shares at IPO Price >KARD

  Moomoo · Nov 9, 6:36 PM EST

• Kardigan Extends Phase 2 Ataciguat Trial Assessment, Targets 2027 Results

  marketbeat.com · Nov 7, 11:14 AM EST

• Kardigan, Inc. (KARD) Discusses Aortic Stenosis Progression Data and KATALYST-AV Baseline Findings - Slideshow

  Seeking Alpha · Nov 7, 10:05 AM EST

• Kardigan, Inc. (KARD) stock price, news, quote and history

  Yahoo Finance UK · Nov 7, 8:24 AM EST

• Kardigan (Nasdaq:KARD) - Stock Analysis

  Simply Wall St · Nov 7, 3:00 AM EST

• Kardigan (KARD) Completes Enrollment in KATALYST-AV Trial for Ao

  GuruFocus · Nov 6, 6:16 PM EST

• Kardigan completes enrollment in Phase 2b aortic stenosis trial

  Investing.com · Nov 6, 4:19 PM EST

• Form 8K Kardigan For: 6 November By Investing.com

  Investing.com UK · Nov 6, 4:12 PM EST

• Kardigan Completes Enrollment in Phase 2b KATALYST-AV Trial and Announces New Evidence Supporting Patient Selection and Endpoints for the Evaluation of Ataciguat in Aortic Stenosis

  Yahoo Finance · Nov 6, 4:05 PM EST

• Kardigan completes Phase 2b KATALYST-AV enrolment testing ataciguat against aortic stenosis

  Dealroom · Nov 6, 3:00 AM EST

• HC Wainwright & Co. initiates coverage of Kardigan at Buy, sets price target at $42

  TradingView · Nov 4, 7:34 AM EST

Kardigan, Inc. key financials

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

• 8-K8-K2026-11-06
• 8-K8-K2026-09-30
• 10-Q10-Q2026-08-11
• 8-K8-K2026-08-11
• 8-K8-K2026-06-23
• S-1S-12026-05-26

About Kardigan, Inc.

Ticker

KARD (Nasdaq)

Industry

Pharmaceutical Preparations

Headquarters

South San Francisco, CA

Incorporated in

DE

Fiscal year end

December 31

SEC CIK

2123613

Frequently asked questions